Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132763) titled 'FihoeLix S- equol capsule is helpful to improve the efficacy and safety of perimenopausal syndrome' on Sept. 18.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Hangzhou Red Cross Hospital

Condition: Perimenopausal syndrome

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-09-23

Target Sample Size: test team:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=343252

Published by HT Digital Content Services with permission from Health Daily Digest....